Fusion energy value chain: Fusion supplier spending is already creating investable value-chain opportunities before commercial reactors

Overview

This Barclays thematic report maps the fusion-energy supply chain rather than recommending individual securities. Its central conclusion is that commercial fusion remains distant, but procurement for prototypes, demonstrators, qualification and construction is already creating revenue opportunities for suppliers of enabling technologies.

Core views

Barclays maintains a base case for commercial fusion in the 2040s, with a bull case in the 2030s, but argues that investors need not wait for ignition or grid-scale deployment to gain exposure. Fusion developers are already building prototypes and demonstrators, and reported c.$540mn of supply-chain spending in 2025, projected to increase to $680mn in 2026. This spending supports suppliers of high-specification hardware and technical services before reactor economics are proven. The report stresses that whole-system engineering breakeven has not yet been demonstrated and that materials durability, specialty-component manufacturing, tritium self-sufficiency and unit economics remain unresolved. The report ranks twelve enabling sectors by current monetisation, product scarcity and protection from dual-use end-markets. HTS tape and magnet systems, precision engineering and vacuum equipment, power electronics and plasma heating, and cryogenics and industrial gases rank most favorably because fusion developers are procuring them today and the same capabilities serve healthcare, defence, aerospace, semiconductors, conventional nuclear and grids. This diversification can reduce dependence on a single fusion developer's timetable. By contrast, thermal blankets, fuel-cycle systems, advanced materials and lasers have meaningful potential but depend more heavily on qualification, reactor design choices or programme progress. Grid equipment and turbines are the least direct near-term exposure because they are ordered only when plants export electricity. HTS tape enables stronger magnetic fields to confine plasma, allowing more compact reactor designs. A SPARC-scale prototype requires c.10,000 km of REBCO tape, and commercial plants would require substantially more. Barclays highlights Fujikura's current supply to Commonwealth Fusion Systems, its JPY11.6bn REBCO capacity investment—JPY6bn intended to triple production by 2027 and JPY5.6bn for a plant expected to start operating in 2028—and Faraday Factory Japan's delivery of over 10,000 km of tape. The investment logic rests on constrained qualified capacity and applications beyond fusion, although eventual commercial-scale demand remains uncertain. Precision manufacturing, vacuum systems and cryogenics are presented as particularly early and predictable spending areas. Developers must buy bespoke vacuum vessels, cryostats, seals, valves, plasma-facing parts and welded structures while building research and demonstration machines; paid feasibility, design and qualification work also precedes construction. Freemelt's order for more than 30,000 tungsten components for JT-60SA has a c.$5.7mn base value and up to c.$8.7mn with options. Cryogenic plants, helium, refrigeration, cryostats and related equipment are required before first plasma, making them independent of whether a reactor ultimately reaches commercial scale. However, Barclays notes that fusion demand is unlikely in the near term to materially affect industrial-gas majors such as Air Liquide and Linde. The report identifies other links in the chain with different revenue timing. Power electronics, RF heating and pulsed-power systems are required for research facilities and prototypes, while diagnostics, simulation and control software can generate recurring development-stage revenue as programmes iterate. Engineering, construction and regulatory services receive front-loaded contracts for plant design, safety cases, licensing, construction management and commissioning; scarcity of nuclear-qualified personnel and licensing experience is a differentiator, though fusion is generally a small part of diversified groups' earnings. Fuel-cycle work currently centers on tritium handling, isotope processing, engineering and licensing, since commercial fuel sales depend on deployment. Thermal blankets, plasma-facing materials and lasers are technologically essential but face qualification, design and durability uncertainty. Barclays views remote handling and lifecycle services as a potentially recurring long-term opportunity because first walls, divertors and blankets degrade and must be replaced robotically. Current revenue, however, is concentrated in fission decommissioning, with fusion-specific activity emerging later. Power conversion, turbines and grid infrastructure may become the largest eventual end-market, but only after commercial deployment; near-term earnings for GE Vernova, Siemens Energy, ABB and Hitachi Energy are driven more by electrification, grid modernisation and data-centre demand than by fusion. Overall, the report frames fusion as an incremental, long-duration theme best accessed today through suppliers with disclosed orders or relevant capacity and substantial non-fusion businesses.

Analysis framework

Barclays maps the fusion value chain across twelve enabling sectors and assesses each using revenue timing and visibility, scarcity of qualified supply, and breadth of adjacent-market demand. It then identifies public and private companies with disclosed fusion orders or programmes, separating direct current exposure from longer-dated capability-based exposure.

Methodology notes

• Competition & strategyValue chain analysis

  Fusion value-chain mapping

  The report traces the technologies and services needed from prototype construction through plant operation, identifying where supplier revenue can arise before commercial fusion.

• Industry AnalysisSupply-demand framework

  Supplier spending, qualification scarcity and procurement timing

  Barclays evaluates sectors by current developer purchasing, the limited number of qualified suppliers, and how soon each component or service is required in the build cycle.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Fujikura

  Direct HTS tape supplier to fusion developers and capacity-expansion beneficiary.

  Strengths

  Supplies REBCO HTS tape to CFS and is investing JPY11.6bn in related capacity.

  Weaknesses

  Commercial-scale fusion demand remains uncertain.

  Comparison

  Barclays believes Fujikura has the greatest relative exposure among the highlighted HTS companies.

  Risks

  Fusion demand and capacity utilisation depend on developer progress.

• Freemelt

  Precision-engineering and advanced-materials supplier with contracted fusion-component production.

  Strengths

  More than 30,000 tungsten-component order for JT-60SA.

  Weaknesses

  Transition from bespoke work to repeat orders remains uncertain.

  Comparison

  Represents clearer current contract evidence than capability-only material suppliers.

  Risks

  Contract execution and follow-on order visibility.

• Air Liquide

  Cryogenic-system integrator with fusion infrastructure exposure.

  Strengths

  Delivered and commissioned ITER cryogenic infrastructure.

  Weaknesses

  Fusion is unlikely to be material to near-term earnings.

  Comparison

  Offers diversified exposure through a large industrial-gases business.

  Risks

  Fusion contracts remain incremental relative to its broader order book.

• BWX Technologies

  Fuel-cycle and tritium-system participant through Kinectrics.

  Strengths

  Design and fabrication partner for the H3AT Tritium Loop Facility.

  Weaknesses

  Commercial fusion-fuel sales are longer dated.

  Comparison

  One of few public exposures in a largely private fuel-cycle supplier landscape.

  Risks

  Tritium-system revenue depends on programme progression and qualification.

• Materion

  Advanced-materials supplier to future fusion thermal and blanket systems.

  Strengths

  Direct supply agreement with Commonwealth Fusion Systems for beryllium fluoride for FLiBe molten salt.

  Weaknesses

  Longer-term materials opportunity is less certain.

  Comparison

  Has a clearer route to fusion revenue than a generic materials-capability claim.

  Risks

  Demand depends on reactor design, qualification and plant deployment.

• Siemens AG

  Digital-control and simulation supplier with a fusion digital-twin collaboration.

  Strengths

  Collaboration with Commonwealth Fusion Systems and NVIDIA on a SPARC digital twin.

  Weaknesses

  Fusion is a small component of a broader industrial business.

  Comparison

  Offers named listed exposure in a field dominated by private specialists.

  Risks

  Fusion-related revenue remains difficult to isolate.

Key data

• Fusion supply-chain spendingc.$540mn in 2025Reported spending by fusion companies as prototype and demonstrator construction progresses.
• Projected fusion supply-chain spending$680mn in 2026Projected increase from 2025.
• Commercial fusion timeline2040s base case; 2030s bull caseBarclays' timeline for commercial fusion.
• SPARC HTS tape requirementc.10,000 km of REBCO HTS tapeApproximate requirement for a single fusion prototype.
• Fujikura REBCO investmentJPY11.6bnIncludes JPY6bn intended to triple production by 2027 and JPY5.6bn for a plant expected to operate in 2028.
• Freemelt JT-60SA orderc.$5.7mn base value, up to c.$8.7mn with optionsOrder for more than 30,000 tungsten components.
• Amplitude laser agreement$40mnAgreement with Focused Energy for two kilojoule-class, high-repetition-rate laser systems.

Impact & implications

The report argues that the most accessible current fusion exposure lies in suppliers whose products are procured during research, prototype construction and qualification, rather than in future power-generation equipment. Dual-use revenue can cushion delays in commercial fusion, but it may also dilute the materiality of fusion to large listed companies' earnings.

Risks

• No fusion system has yet demonstrated whole-system engineering breakeven, while materials durability, specialty-component manufacturing, tritium self-sufficiency and unit economics remain unresolved.
• Commercial fusion timelines may slip, reducing the timing and scale of longer-dated supplier demand.
• Many listed suppliers have diversified businesses, so fusion revenue may not be material to earnings in the near term.
• Qualification, reactor-design selection, contract terms and execution will determine whether capability translates into commercial orders.
• Future reactor fleets may use different materials, laser architectures and fuel-cycle designs than currently anticipated.

What to watch

• Growth in developer procurement, qualification activity and demonstrator construction spending.
• HTS tape capacity additions and orders from fusion developers.
• Disclosed contracts for cryogenic systems, precision components, fuel-cycle equipment and engineering services.
• Progress on tritium breeding and recycling, materials qualification and reactor unit economics.
• Licensing developments and the ability of engineering firms to secure nuclear safety-case and regulatory work.
• Evidence that specialist private suppliers expand, disclose fusion revenue or enter public markets.